68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(8 sites)

China

Peking University First Hospital, Beijing

Xiangya Hospital Central South University, Changsha

Nanfang Hospital Southern Medical University, Guangzhou

Fudan University Shanghai Cancer Center, Shanghai

West China Hospital of Sichuan University, Sichuan

Wuhan Union Hospital, Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

Affiliated Hosptial of Jiangnan University, Wuxi